Cargando…
Immune Globulin Subcutaneous (Human) 20%: In Primary Immunodeficiency Disorders
Immune globulin subcutaneous 20% is a new high-concentration (200 g/L) solution of highly purified human IgG (≥98%) indicated in the EU and the US for antibody replacement therapy in patients with primary immunodeficiency with antibody deficiency, and in the EU for replacement therapy in humoral imm...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582812/ https://www.ncbi.nlm.nih.gov/pubmed/22621695 http://dx.doi.org/10.2165/11209490-000000000-00000 |